E

Everest Organics Limited

EVERESTO
Market snapshot · 2026-08-11 19:16 UTC

300.15

+₹5.15 (+1.75%)

MARKET CAP

₹291.46 Cr

STOCK P/E

52.8x

52W HIGH

₹536.40

52W LOW

₹197.00

BOOK VALUE

₹77.22

EPS

₹5.69

ROE

7.63%

SECTOR

Healthcare

DEBT/EQUITY

66.16

VOLUME

777

P/B RATIO

3.89x

PEG RATIO

Sector

Healthcare

Themes

Drug Manufacturers - Specialty & Generic

Loading chart…

AI Summary

✦ Clartha

Valuation Metrics

Trading 20.1% above historical median. Valuation is rising — currently in the fair zone (z-score: +0.47). Confidence: 52%.

Forward Valuation Outlook

Forward outlook is unavailable because live next-12-month estimate data is not available for this ticker right now.

P/E
Fair

5Y Average

37.67

Current

52.75

Overvalued

58.39

Undervalued

23.30

EV/EBITDA
Overvalued

5Y Average

11.62

Current

16.27

Overvalued

16.19

Undervalued

6.87

P/S
Strongly Overvalued

5Y Average

1.05

Current

1.48

Overvalued

1.21

Undervalued

0.90

Peers & Comparison

No peer data available for this company.
WHY THESE PEERS

No sector data available for this company.

Financials

Real statement data for revenue, earnings quality, conversion, and balance-sheet coverage. Monetary values are shown in Rs crore.

Latest revenue

₹49 CrMar 2026

Latest net profit

₹2.63 CrMar 2026

Latest EPS

₹2.71Mar 2026

Net margin

13.7%Mar 2026

Performance

Bars show revenue and net profit. The line shows net margin.

Rs crore + margin %
Q4 '25Q1 '26Q2 '26Q3 '26Q4 '260.0%4.0%8.0%12.0%16.0%0.00 Cr15 Cr30 Cr45 Cr60 Cr
  • Revenue
  • Net income
  • Net margin %

Earnings

Revenue is shown in crores. EPS is rupees per share.

Rs crore + Rs/share
Q4 '25Q1 '26Q2 '26Q3 '26Q4 '260.00 Cr15 Cr30 Cr45 Cr60 Cr₹0₹1₹2₹2₹3
  • Revenue
  • EPS

Revenue to profit conversion

Bridge from operating numbers to profit for the latest reported period.

Rs crore
RevenueExpensesDepreciationOtheradjustmentsOperatingprofitOther incomeInterestOtheradjustmentsProfitbefore taxTax & otherOtheradjustmentsNet Profit0.00 Cr15 Cr30 Cr45 Cr60 Cr

Latest reported period: Mar 2026

Debt level and coverage

Debt, cash and free cash flow compared on the same crore scale.

Rs crore
Annual view
Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026-80 Cr0.00 Cr80 Cr160 Cr240 Cr
  • Debt
  • Free cash flow
  • Cash & equivalents

Results

MetricMar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026
Sales +50.7542.6749.4552.5152.6232.4544.0542.0540.9353.8151.0042.5948.75
Expenses +48.4740.1546.7449.7149.6736.1140.6238.0337.4949.3745.8739.0542.05
Operating Profit2.282.522.712.802.95-3.663.434.023.444.445.133.546.70
OPM %4.49%5.91%5.48%5.33%5.61%-11.28%7.79%9.56%8.40%8.25%10.06%8.31%13.74%
Other Income +0.690.220.240.130.300.330.140.000.220.550.290.250.16
Interest0.951.291.491.451.241.291.351.401.151.311.231.232.76
Depreciation1.261.291.321.331.851.471.471.471.561.521.521.521.93
Profit before tax0.760.160.140.150.16-6.090.751.150.952.162.671.042.17
Tax %85.53%75.00%78.57%93.33%62.50%0.00%1.33%0.87%-206.32%35.19%56.93%65.38%-21.20%
Net Profit +0.110.040.030.020.06-6.090.741.142.911.411.160.362.63
EPS in Rs0.140.050.040.020.08-7.610.921.423.001.451.190.372.71
Raw PDF

All values in ₹ Crores unless otherwise stated. Source: Screener Master (Standalone).

Shareholding Pattern

HolderJun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Promoters +60.99%59.64%59.61%59.58%59.60%
DIIs +0.02%0.02%0.02%0.02%0.02%
Public +38.99%40.35%40.36%40.40%40.38%
Others0.01%
Jun 2026
Promoters +
DIIs +
Public +

Events Timeline

Board Meeting Intimation for Meeting Scheduled To Be Held On Friday, August 14, 2026

Aug 06, 2026PDFCompany Reports Open

Announcement under Regulation 30 (LODR)-Allotment

Jul 11, 2026PDFCompany Reports Open

Closure of Trading Window

Jun 24, 2026PDFCompany Reports Open

Announcement under Regulation 30 (LODR)-Cessation

Jun 22, 2026PDFCompany Reports Open

Announcement under Regulation 30 (LODR)-Newspaper Publication

Jun 01, 2026PDFCompany Reports Open